JP2011520108A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520108A5
JP2011520108A5 JP2011507627A JP2011507627A JP2011520108A5 JP 2011520108 A5 JP2011520108 A5 JP 2011520108A5 JP 2011507627 A JP2011507627 A JP 2011507627A JP 2011507627 A JP2011507627 A JP 2011507627A JP 2011520108 A5 JP2011520108 A5 JP 2011520108A5
Authority
JP
Japan
Prior art keywords
prion
pathogenic conformer
conformer
pathogenic
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011507627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011520108A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/042185 external-priority patent/WO2009134942A1/en
Publication of JP2011520108A publication Critical patent/JP2011520108A/ja
Publication of JP2011520108A5 publication Critical patent/JP2011520108A5/ja
Withdrawn legal-status Critical Current

Links

JP2011507627A 2008-04-30 2009-04-29 病原性配座異性体についてのアッセイ Withdrawn JP2011520108A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4939608P 2008-04-30 2008-04-30
US61/049,396 2008-04-30
PCT/US2009/042185 WO2009134942A1 (en) 2008-04-30 2009-04-29 Assay for pathogenic conformers

Publications (2)

Publication Number Publication Date
JP2011520108A JP2011520108A (ja) 2011-07-14
JP2011520108A5 true JP2011520108A5 (enExample) 2013-04-25

Family

ID=40863365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011507627A Withdrawn JP2011520108A (ja) 2008-04-30 2009-04-29 病原性配座異性体についてのアッセイ

Country Status (8)

Country Link
US (1) US20110189692A1 (enExample)
EP (1) EP2282753A1 (enExample)
JP (1) JP2011520108A (enExample)
CN (1) CN102083450A (enExample)
AU (1) AU2009243060A1 (enExample)
BR (1) BRPI0910550A2 (enExample)
CA (1) CA2721982A1 (enExample)
WO (1) WO2009134942A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130273573A1 (en) * 2009-11-30 2013-10-17 Novartis Ag Amyloid beta aggregates in cerebro spinal fluid as biomarkers for alzheimer's disease
JP5747444B2 (ja) * 2010-04-27 2015-07-15 パナソニックヘルスケア株式会社 βアミロイドに関連する病的状態の診断補助方法
JP2013227243A (ja) * 2012-04-25 2013-11-07 Shiga Univ Of Medical Science アミロイドβ蛋白凝集体結合化合物とその用途
GB201513444D0 (en) * 2015-07-30 2015-09-16 Univ Durham Peptoid
GB201518675D0 (en) 2015-10-21 2015-12-02 Cellcap Technologies Ltd Detection of structural forms of proteins
JP2018538302A (ja) * 2015-12-15 2018-12-27 サレプタ セラピューティクス， インコーポレイテッド ペプチドオリゴヌクレオチド複合体
US11053282B2 (en) 2016-03-09 2021-07-06 Mike-Ann, Llc Peptoid affinity ligands
EP3951389A4 (en) * 2019-03-29 2022-12-14 Sekisui Medical Co., Ltd. IMMUNOLOGICAL ASSAY REAGENT AND IMMUNOLOGICAL ASSAY METHOD

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999015903A1 (de) * 1997-09-19 1999-04-01 Evotec Biosystems Ag Verfahren zur messung der assoziation von teilstrukturen pathologischer proteinablagerungen
US4006117A (en) * 1973-01-24 1977-02-01 Hooker Chemicals & Plastics Corporation Amine phosphite antioxidants
US3843443A (en) * 1973-03-30 1974-10-22 J Fishman Polypeptide materials bound to fluorocarbon polymers
US4244721A (en) * 1979-01-31 1981-01-13 Pedro Buarque De Macedo Method of making composite borosilicate glass articles
US4507230A (en) * 1982-05-12 1985-03-26 Research Corporation Peptide synthesis reagents and method of use
US4952496A (en) * 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
DE3500180A1 (de) * 1985-01-04 1986-07-10 Ernst Prof. Dr. 7400 Tübingen Bayer Pfropfcopolymerisate aus vernetzten polymeren und polyoxyethylen, verfahren zu ihrer herstellung und ihre verwendung
US5292814A (en) * 1987-04-29 1994-03-08 Ernst Bayer Process for the preparation of monodispersed polymer beads
ES2082850T3 (es) * 1989-02-24 1996-04-01 Univ California Inmunoglobulinas preparadas geneticamente.
US5231167A (en) * 1989-09-08 1993-07-27 The Regents Of The University Of California Immunoglobulin-binding polypeptides
US5306812A (en) * 1989-09-08 1994-04-26 The Regents Of The University Of California Immunoglobulin-binding polypeptides
US5965695A (en) * 1990-05-15 1999-10-12 Chiron Corporation Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
ATE197646T1 (de) * 1990-08-06 2000-12-15 Chiron Corp Verfahren zum nachweis von cytokinkonvertasehemmern
EP0620761A1 (en) * 1991-01-04 1994-10-26 Perseptive Biosystems, Inc. Sulfonamide bonded hydrophilic coatings
US5665539A (en) * 1991-07-12 1997-09-09 The Regents Of The University Of California Immuno-polymerase chain reaction system for antigen detection
US5846717A (en) * 1996-01-24 1998-12-08 Third Wave Technologies, Inc. Detection of nucleic acid sequences by invader-directed cleavage
DK0616613T3 (da) * 1991-12-03 1999-09-27 Proteus Molecular Design Fragmenter af prionprotein
US5424413A (en) * 1992-01-22 1995-06-13 Gen-Probe Incorporated Branched nucleic acid probes
TW327194B (en) * 1992-05-01 1998-02-21 American Cyanamid Co Novel amyloid precursor proteins and methods of using same
US5877278A (en) * 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
US5831005A (en) * 1992-09-24 1998-11-03 Chiron Corporation Synthesis of N-substituted oligomers
US5652138A (en) * 1992-09-30 1997-07-29 The Scripps Research Institute Human neutralizing monoclonal antibodies to human immunodeficiency virus
US5681697A (en) * 1993-12-08 1997-10-28 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor
US5792901A (en) * 1994-05-13 1998-08-11 The Regents Of The University Of California Detecting prions in a sample and prion preparation and transgenic animal used for same
US5908969A (en) * 1994-05-13 1999-06-01 The Regents Of The University Of California Method of detecting prions in a sample and transgenic animal used for same
US5565186A (en) * 1994-05-13 1996-10-15 The Regents Of The University Of California Method of detecting prions in a sample and transgenic animal used for same
US6168776B1 (en) * 1994-07-19 2001-01-02 University Of Pittsburgh Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US6376170B1 (en) * 1994-10-03 2002-04-23 The Scripps Research Institute Ligand capture-directed selection of antibody
US5639581A (en) * 1994-10-24 1997-06-17 Fuji Xerox Co., Ltd. Charge transporting polymer, process for producing the same, and organic electronic device containing the same
US5854215A (en) * 1995-03-14 1998-12-29 Praecis Pharmaceuticals Incorporated Modulators of β-amyloid peptide aggregation
US5948763A (en) * 1995-06-07 1999-09-07 New York University Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
EP0852011B1 (en) * 1995-09-14 2004-03-31 The Regents of the University of California ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc
US5750361A (en) * 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
US6090606A (en) * 1996-01-24 2000-07-18 Third Wave Technologies, Inc. Cleavage agents
US5985557A (en) * 1996-01-24 1999-11-16 Third Wave Technologies, Inc. Invasive cleavage of nucleic acids
US6586193B2 (en) * 1996-04-25 2003-07-01 Genicon Sciences Corporation Analyte assay using particulate labels
ATE252914T1 (de) * 1996-08-13 2003-11-15 Chiron Corp Zusammensetzungen zur polynukleotidabgabe
US6172043B1 (en) * 1997-01-10 2001-01-09 Massachusetts Institute Of Technology Treatments for neurotoxicity in Alzheimer's disease caused by β amyloid peptides
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
US20010001061A1 (en) * 1997-02-21 2001-05-10 Prusiner Stanley B. Assay for disease related conformation of a protein
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
US7005295B1 (en) * 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
US6787319B2 (en) * 1997-04-16 2004-09-07 American Home Products Corp. β-amyloid peptide-binding proteins and polynucleotides encoding the same
ES2329955T3 (es) * 1997-04-28 2009-12-02 Novartis Vaccines And Diagnostics, Inc. Aparato para la sintesis de oligomeros, especialmente peptoides, con reciclado de reactivos.
US5962669A (en) * 1997-06-02 1999-10-05 The Regents Of The University Of California Nucleic acid encoding prion protein variant
US6214565B1 (en) * 1998-10-09 2001-04-10 The Regents Of The University Of California Assay for disease related conformation of a protein and isolating same
DK1073723T3 (da) * 1998-04-14 2006-01-02 Sugen Inc STE20-relaterede proteinkinaser
US6211149B1 (en) * 1998-08-03 2001-04-03 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors of formation of protease resistant prion protein
GB2348203B (en) * 1998-11-04 2002-06-19 Imp College Innovations Ltd Solube beta-forms of prion proteins, methods of preparation and use
US6551843B1 (en) * 1999-01-29 2003-04-22 Immunivest Corporation Methods for enhancing binding interactions between members of specific binding pairs
FR2801106B1 (fr) * 1999-11-12 2007-10-05 Commissariat Energie Atomique Procede de diagnostic d'une esst provoquee par une souche d'atnc dans un echantillon biologique et son utilisation dans le diagnostic differentiel des differentes souches d'atnc
US6235483B1 (en) * 2000-01-31 2001-05-22 Agilent Technologies, Inc. Methods and kits for indirect labeling of nucleic acids
KR20020081330A (ko) * 2000-02-16 2002-10-26 노오쓰웨스턴 유니버시티 폴리펩토이드 폐 계면활성제
EP1272509A2 (en) * 2000-04-05 2003-01-08 V.I. Technologies, Inc. Prion-binding peptidic ligands and methods of using same
US6511809B2 (en) * 2000-06-13 2003-01-28 E. I. Du Pont De Nemours And Company Method for the detection of an analyte by means of a nucleic acid reporter
WO2001097785A2 (en) * 2000-06-20 2001-12-27 Caprion Pharmaceuticals Inc. Basic copolymers for the treatment of prion-related-disease
CN1176407C (zh) * 2000-06-22 2004-11-17 京瓷株式会社 彩色图像形成装置及其方法
US6537548B1 (en) * 2000-07-27 2003-03-25 The Regents Of The University Of California Antibodies specific for ungulate PrP
US20030092613A1 (en) * 2000-08-14 2003-05-15 Lee Daniel H. S. Alpha7 nicotinic receptor peptides as ligands for beta amyloid peptides
US6721761B2 (en) * 2000-12-20 2004-04-13 American Management Systems, Inc. System for assigning digital identifiers to telephone numbers and IP numbers
US7166471B2 (en) * 2001-05-31 2007-01-23 Arete Associates Misfolded protein sensor method in body fluids
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
AU2002357007A1 (en) * 2001-11-21 2003-06-10 New York University SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID Beta, PRION PROTEIN, AMYLIN, Alpha-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO
US20040052928A1 (en) * 2002-09-06 2004-03-18 Ehud Gazit Peptides and methods using same for diagnosing and treating amyloid-associated diseases
MXPA04008275A (es) * 2002-02-28 2005-04-25 Microsens Biophage Ltd Enlace de formas patologicas de proteinas de prion.
JP4421900B2 (ja) * 2002-04-09 2010-02-24 ザ スクリップス リサーチ インスティテュート モチーフ・グラフトされたハイブリッドポリペプチドおよびその使用
US20040208919A1 (en) * 2002-06-13 2004-10-21 Nicolau Yves C. Vaccination against prion diseases
DE10230141B4 (de) * 2002-07-04 2004-07-15 Priontype Gmbh Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
EP1382971A1 (en) * 2002-07-17 2004-01-21 Pepscan Systems B.V. Detection of prion disease
US20040072236A1 (en) * 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
US7863411B2 (en) * 2002-12-03 2011-01-04 Pathogen Removal and Diagnostics Technologies Inc. Prion protein ligands and methods of use
WO2004090102A2 (en) * 2003-04-04 2004-10-21 American Red Cross Prion protein binding materials and methods of use
US7745569B2 (en) * 2003-04-07 2010-06-29 The Regents Of The University Of California Amyloid specific binding peptides and detecting abeta peptide
WO2005016127A2 (en) * 2003-08-13 2005-02-24 Chiron Corporation Prion-specific peptide reagents
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
JP3910569B2 (ja) * 2003-08-19 2007-04-25 独立行政法人科学技術振興機構 アミロイドβ蛋白質のアミロイド線維化を増幅するための試薬
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
US7482172B2 (en) * 2005-09-19 2009-01-27 Ortho-Clinical Diagnostics, Inc. Peptides for discrimination of prions
AU2006204705C1 (en) * 2005-01-13 2012-07-05 Novartis Vaccines And Diagnostics, Inc. ELISA assays using prion-specific peptide reagents
EP1848830A4 (en) * 2005-01-13 2009-05-06 Novartis Vaccines & Diagnostic Osplation of pathogenic prions
NZ594844A (en) * 2005-09-09 2013-04-26 Novartis Ag Prion-specific peptoid reagents
EP2152744A4 (en) * 2007-04-26 2012-02-15 Univ Yale PRION PROTEIN AS RECEPTOR FOR AMYLOID-BETA OLIGOMERS

Similar Documents

Publication Publication Date Title
JP2011520108A5 (enExample)
JP6980750B2 (ja) アルファ−シヌクレイン検出アッセイ及びアルファ−シヌクレイン病を診断するための方法
AU2014311258B2 (en) Method of identifying biomarkers of neurological diseases and diagnosis of neurological diseases
AU2011261308C1 (en) Markers for renal disease
JP2012080899A5 (enExample)
EP2579042B1 (en) Method for detecting Aß-specific antibodies in a biological sample
EP3523653B1 (en) Rep protein as protein antigen for use in diagnostic assays
CA2597912C (en) Method for detecting misfolded proteins and prions
EP3287789B1 (en) Composition and kit for diagnosing behavioral addiction, and method of detecting neuropilin-2 for diagnosis of behavioral addiction
EP3349012B1 (en) Use of a composition for diagnosing behavioural addiction and method of detecting sphingosine 1-phosphate receptor 1 for diagnosis of behavioural addiction
TW201805627A (zh) 使用尿液生物標記之阿茲海默氏症之輔助診斷方法
EP2787347A1 (en) Method for detecting Aß-specific antibodies in a biological sample
WO2022221876A1 (en) Digital protein misfolding assays
AU4297400A (en) Method of diagnosing transmissible spongiform encephalopathies
JP2007502837A5 (enExample)
US20120178177A1 (en) Biological Components Within the Cerebrospinal Fluid
JP2004528561A (ja) プリオンタンパク質含有サンプルをＰｒＰＳｃ型の存在可能性について試験する方法
JP7349104B2 (ja) ベロ毒素の検出方法
JP2022550825A (ja) 尿サンプル中において結核の診断を行なうための方法
JP4701391B2 (ja) ＩｇＡ腎症関連抗体の検出法
WO2023164414A2 (en) Methods and compositions for evaluating biomarkers in salivary exosomes and evaluating cognitive fatigue
TWI382178B (zh) 偵測樣品中生物分子之方法
IT202200001400A1 (it) Metodo di diagnosi della malattia di Alzheimer
WO2008148490A1 (en) Hsp27 as biomarker for alzheimer's disease
HK1178601B (en) METHOD FOR DETECTING Aß-SPECIFIC ANTIBODIES IN A BIOLOGICAL SAMPLE